Cognition Therapeutics Receives $3.3 Million NIA Grant to Conduct qEEG Study of Elayta™ with World-Leading Alzheimer’s Biomarker Experts
BioSpace
, July 9th, 2019
Complexa Announces Presentation of Phase 1 Data Evaluating Lead Candidate CXA-10 as a Disease-Modifying Therapy in Pulmonary Arterial Hypertension at PHA’s 2018 International PH Conference
Press Release
, June 28th, 2019
The path to be first — How Carmell Therapeutics could have the 1st BLA-certified regenerative offering for bone healing
Becker's Spine
, June 25th, 2019
Rinovum Women’s Health Debuts All-New Over-the-Counter Product Designed to Treat Stress Urinary Incontinence and Boost Women’s Confidence
Intrado
, June 18th, 2019
Cognition Therapeutics Appoints Anthony O. Caggiano M.D., Ph.D. to the Position of Chief Medical Officer
Press Release
, June 5th, 2019
ALung Announces that the Independent Data and Safety Monitoring Board (DSMB) Recommends Continuation of VENT-AVOID Trial and Reports that Significant Progress Continues with their Clinical Trial Programs
Press Release
, May 9th, 2019
ALung’s worldwide trials are underway for their artificial lung
Next Pittsburgh
, April 22nd, 2019
Pittsburgh health care firm expanding services to help employers cut costs
Pittsburgh Business Times
, April 19th, 2019
Toward A More Robust Regenerative Medicine Regulatory Pathway
Cell & Gene
, April 11th, 2019
News & Information
Press Release
, April 9th, 2019